Bivalirudin and transradial access - The end of the bleeding era for catheterization procedures

Journal of Invasive Cardiology

Volumn 23, Issue 3, 2011, Pages 105-106

  Badheka, Apurva ^a   Cohen, Mauricio G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PRASUGREL;

ANTICOAGULANT THERAPY; ARTERY OCCLUSION; BLEEDING; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS GRAFT; FEMORAL ARTERY; HEART CATHETERIZATION; HEMATOMA; HUMAN; LENGTH OF STAY; LOW DRUG DOSE; MORBIDITY; MORTALITY; NOTE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; RADIAL ARTERY; RETROPERITONEAL HEMORRHAGE; RISK REDUCTION; VASCULAR ACCESS;

EID: 80155207361     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Note

References (21)

1. Yatskar L, Selzer F, Feit F, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: Data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 2007;69:961-966. (Pubitemid 46897929)
2. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1815-1823. (Pubitemid 37280247)
3. Doyle BJ, Ting HH, Bell MR, et al. Major femoral bleeding complications after percutaneous coronary intervention: Incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. J Am Coll Cardiol Intv 2008;1:202-209. (Pubitemid 351506552)
4. Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn 1989;16:3-7. (Pubitemid 19033502)
5. Kiemeneij F, Laarman GJ. Percutaneous transradial artery approach for coronary stent implantation. Cathet Cardiovasc Diagn 1993;30:173-178. (Pubitemid 23292091)
6. Vorobcsuk A, Konyi A, Aradi D, et al. Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction: Systematic overview and metaanalysis. Am Heart J 2009;158:814-821.
7. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: A report from the National Cardiovascular Data Registry. J Am Coll Cardiol Intv 2008;1:379-386.
8. Jolly SS, Amlani S, Hamon M, et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials. Am Heart J 2009;157:132-140.
9. Rao SV, Cohen MG, Kandzari DE, et al. The transradial approach to percutaneous coronary intervention: Historical perspective, current concepts, and future directions. J Am Coll Cardiol 2010;55:2187-2195.
10. Martinez CA, Cohen MG. Left or right, transradial access for all. J Invasive Cardiol 2010;22:398-399.
11. Bertrand OF, Rao SV, Pancholy S, et al. Transradial approach for coronary angiography and interventions: Results of the first international transradial practice survey. J Am Coll Cardiol Intv 2010;3:1022-1031.
12. Sciahbasi A, Romagnoli E, Burzotta F, et al. Transradial approach (left vs. right) and procedural times during percutaneous coronary procedures: TALENT study. Am Heart J 2011;161:172-179.
13. Lincoff AM, Kleiman NS, Kereiakes DJ, et al. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs. heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 2004;292:696-703. (Pubitemid 39062523)
14. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006;355:2203-2216. (Pubitemid 44791162)
15. Hamon M, Rasmussen LH, Manoukian SV, et al. Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial. EuroIntervention 2009;5:115-120.
16. Singh A, Edasery D, Noor A, et al. Use of low-dose heparin with bivalirudin for ad hoc transradial coronary interventions: Experience from a single center. J Invasive Cardiol 2011;23:101-104.
17. Pancholy S, Coppola J, Patel T, Roke-Thomas M. Prevention of radial artery occlusion- patent hemostasis evaluation trial (PROPHET study): A randomized comparison of traditional versus patency documented hemostasis after transradial catheterization. Catheter Cardiovasc Interv 2008;72:335-340.
18. Schiano P, Barbou F, Chenilleau MC, et al. Adjusted weight anticoagulation for radial approach in elective coronarography: The AWARE coronarography study. EuroIntervention 2010;6:247-250.
19. Venkatesh K, Mann T. Transitioning from heparin to bivalirudin in patients undergoing ad hoc transradial interventional procedures: A pilot study. J Invasive Cardiol 2006;18:120-124.
20. Plante S, Cantor WJ, Goldman L, et al. Comparison of bivalirudin versus heparin on radial artery occlusion after transradial catheterization. Catheter Cardiovasc Interv 2010;7:654-658.
21. Cortese B, Picchi A, Micheli A, et al. Comparison of prolonged bivalirudin infusion versus intraprocedural in preventing myocardial damage after percutaneous coronary intervention in patients with angina pectoris. Am J Cardiol 2009;104:1063-1068.